Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rind

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetesGregory F Guzauskas, David M Rind, Katherine Fazioli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After LaunchMarina Richardson, Abigail C Wright, Jeffrey A Tice, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2024
The effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary diseaseAbigail C Wright, Grace A Lin, Melanie D Whittington, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 20, 2026
Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidenceMarina Richardson, Abigail C Wright, Shahariar Mohammed Fahim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 18, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder CancerMrinmayee Joshi, Steven J Atlas, Molly Beinfeld, et al.
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
The effectiveness and value of sonpiretigene isteparvovec for the treatment of advanced retinitis pigmentosaBelen Herce-Hagiwara, Avery McKenna, Anil N Makam, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2025
The effectiveness and value of suzetrigine for moderate to severe acute pain: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, David M Rind, Brett McQueen, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2024
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2022
The effectiveness and value of tezepelumab for severe asthmaDavid M Rind, R Brett McQueen, Serina Herron-Smith, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetesGregory F Guzauskas, David M Rind, Katherine Fazioli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After LaunchMarina Richardson, Abigail C Wright, Jeffrey A Tice, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2024
The effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary diseaseAbigail C Wright, Grace A Lin, Melanie D Whittington, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 20, 2026
Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidenceMarina Richardson, Abigail C Wright, Shahariar Mohammed Fahim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 18, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder CancerMrinmayee Joshi, Steven J Atlas, Molly Beinfeld, et al.
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
The effectiveness and value of sonpiretigene isteparvovec for the treatment of advanced retinitis pigmentosaBelen Herce-Hagiwara, Avery McKenna, Anil N Makam, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2025
The effectiveness and value of suzetrigine for moderate to severe acute pain: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, David M Rind, Brett McQueen, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2024
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2022
The effectiveness and value of tezepelumab for severe asthmaDavid M Rind, R Brett McQueen, Serina Herron-Smith, et al.
Pageof 5